Annual Drug Patent Expirations for NORVIR
Norvir is a drug marketed by Abbott, Abbvie, and Abbvie Inc and, and is included in five NDAs. It is available from three suppliers.
Drug patent litigation for NORVIR.
The generic ingredient in NORVIR is ritonavir. Three suppliers are listed for this compound. Additional details are available on the ritonavir profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com